Gruber R, Riedl C C, Reisegger M, Pinker K, Sturm E, Semturs F, Helbich T H
Abteilung für Allgemeine Radiologie und Kinderradiologie, Division für Molekulare und Gender-Bildgebung, Universitätsklinik für Radiodiagnostik, Medizinische Universität Wien, Währinger Gürtel 18-20, A-1090 Wien, Österreich.
Radiologe. 2010 Nov;50(11):999-1007. doi: 10.1007/s00117-010-2010-0.
In Europe one out of every nine women suffers from breast cancer during her lifetime. Since the introduction of mammography screening programs more breast cancers are being diagnosed when they are still small and early stage cancers with a favourable prognosis. The introduction of digital mammography systems has led to a continuous reduction of breast cancer mortality especially in specific patient subgroups. Furthermore, the digital mammography platform enables the development of new, innovative breast imaging methods to increase sensitivity and decrease breast cancer mortality. This digital mammography platform includes digital breast tomosynthesis, digital contrast medium mammography and digital contrast medium breast tomosynthesis as well as fused data sets from digital mammography with ultrasound or MRI. The following article summarizes these new applications, describes the strengths of the digital platform and illustrates the potential advantages of an improved breast cancer diagnosis by digital mammography.
在欧洲，每九名女性中就有一人在其一生中会患乳腺癌。自从引入乳腺钼靶筛查项目以来，越来越多的乳腺癌在仍处于早期且预后良好的小癌症阶段时就被诊断出来。数字乳腺钼靶系统的引入使得乳腺癌死亡率持续下降，尤其是在特定患者亚组中。此外，数字乳腺钼靶平台有助于开发新的、创新的乳腺成像方法，以提高敏感性并降低乳腺癌死亡率。这个数字乳腺钼靶平台包括数字乳腺断层合成、数字对比剂乳腺钼靶和数字对比剂乳腺断层合成，以及来自数字乳腺钼靶与超声或磁共振成像的融合数据集。以下文章总结了这些新应用，描述了数字平台的优势，并说明了通过数字乳腺钼靶改善乳腺癌诊断的潜在益处。
